Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 7, 2011 - Issue 2
Submit an article Journal homepage
251
Views
15
CrossRef citations to date
0
Altmetric
Special Report

DNA double-strand break repair, immunodeficiency and the RIDDLE syndrome

Rachel M Blundred School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK; School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK
&
Grant S Stewart School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK;[email protected]
Pages 169-185 | Published online: 10 Jan 2014

References

  • Hopfner KP, Craig L, Moncalian G et al. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature418(6897), 562–566 (2002).
  • Williams RS, Moncalian G, Williams JS et al. Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell135(1), 97–109 (2008).
  • Uziel T, Lerenthal Y, Moyal L et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J.22, 5612–5621 (2003).
  • Burma S, Chen BP, Murphy M et al. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem.276, 42462–42467 (2001).
  • Stucki M, Clapperton JA, Mohammad D et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell123, 1213–1226 (2005).
  • Stewart GS, Wang B, Bignell CR et al. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature421, 961–966 (2003).
  • Lukas C, Melander F, Stucki M et al. MDC1 couples DNA double-strand break recognition by NBN with its H2AX-dependent chromatin retention. EMBO J.23, 2674–2683 (2004).
  • Huen MS, Grant R, Manke I et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell131, 901–914 (2007).
  • Kolas NK, Chapman JR, Nakada S et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science318, 1637–1640 (2007).
  • Mailand N, Bekker-Jensen S, Faustrup H et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell131, 887–900 (2007).
  • Kim H, Chen J, Yu X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science316, 1202–1205 (2007).
  • Sobhian B, Shao G, Lilli DR et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science316, 1198–1202 (2007).
  • Wang B, Matsuoka S, Ballif BA et al. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science316, 1194–1198 (2007).
  • Feng L, Huang J, Chen J. MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev.23(6), 719–728 (2009).
  • Shao G, Patterson-Fortin J, Messick TE et al. MERIT40 controls BRCA1–Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev.23(6), 740–754 (2009).
  • Wang B, Hurov K, Hofmann K, Elledge SJ. NBA1, a new player in the BRCA1 A complex, is required for DNA damage resistance and checkpoint control. Genes Dev.23(6), 729–739 (2009).
  • Shao G, Lilli DR, Patterson-Fortin J et al. The Rap80–BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc. Natl Acad. Sci. USA106(9), 3166–3171 (2009).
  • Polanowska J, Martin JS, Garcia-Muse T et al. A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J.25, 2178–2188 (2006).
  • Botuyan MV, Lee J, Ward IM et al. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell127(7), 1361–1373 (2006).
  • Schotta G, Sengupta R, Kubicek S et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev.22(15), 2048–2061 (2008).
  • DiTullio RA Jr, Mochan TA, Venere M et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell. Biol.4, 998–1002 (2004).
  • Difilippantonio S, Gapud E, Wong N et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature456, 529–533 (2008).
  • Bunting SF, Callén E, Wong N et al. 53BP1 inhibits homologous recombination in BRAC1-deficient cells by blocking resection of DNA breaks. Cell141(2), 243–254 (2010).
  • Yata K, Esashi F. Dual role of Cdks in DNA repair: to be, or not to be. DNA repair (Amst).8(1), 6–18 (2009).
  • Huertas P. DNA resection in eukaryotes: deciding how to fix the break. Nat. Struct. Mol. Biol.17(1), 11–16 (2010).
  • Sartori AA, Lukas C, Coates J et al. Human CtIP promotes DNA end resection. Nature450(7169), 509–514 (2007).
  • Huertas P, Jackson SP. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J. Biol. Chem.284(14), 9558–9565 (2009).
  • Chen L, Nievera CJ, Lee AY, Wu X. Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair. J. Biol. Chem.283(12), 7713–7720 (2008).
  • Yun MH, Hiom K. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature459(7245), 460–463 (2009).
  • Bouwman P, Aly A, Escandell JM et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol.17(6), 688–695 (2010).
  • Cao L, Xu X, Bunting SF et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol. Cell35(4), 534–541 (2009).
  • Gravel S, Chapman JR, Magill C, Jackson SP. DNA helicases Sgs1 and BLM promote DNA double-strand break resection. Genes Dev.22(20), 2767–2772 (2008).
  • Nimonkar AV, Ozsoy AZ, Genschel J et al. Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. Proc. Natl Acad. Sci. USA105(44), 16906–16911 (2008).
  • Wyman C, Kanaar R. DNA double-strand break repair: all’s well that ends well. Annu. Rev. Genet.40, 363–383 (2006).
  • Mimitou EP, Symington LS. Nucleases and helicases take center stage in homologous recombination. Trends Biochem. Sci.34(5), 264–272 (2009).
  • Muñoz IM, Hain K, Déclais A-C et al. Coordination of structure-specific nucleases by human SLX4/BTB12 is required for DNA repair. Mol. Cell35, 116–127 (2009).
  • Klein H, Symington L. Breaking up just got easier to do. Cell138(1), 20–22 (2009).
  • Aguilera A, Gómez-González B. Genome instability: a mechanistic view of its causes and consequences. Nat. Rev. Genet.9(3), 204–217 (2008).
  • Kühne M, Riballo E, Rief N et al. A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res.64(2), 500–508 (2004).
  • Mari PO, Florea BI, Persengiev SP et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl Acad. Sci. USA103(49), 18597–18602 (2006).
  • Uematsu N, Weterings E, Yano K et al. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. J. Cell. Biol.177(2), 219–229 (2007).
  • Chan DW, Chen BP-C, Prithivirajsingh S et al. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev.16(18), 2333–2338 (2002).
  • Ding Q, Reddy YVR, Wang W et al. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol. Cell Biol.23(16), 5836–5848 (2003).
  • Calsou P, Frit P, Humbert O et al. The DNA-dependent protein kinase catalytic activity regulates DNA end processing by means of Ku entry into DNA. J. Biol. Chem.274(12), 7848–7856 (1999).
  • Weterings E, Verkaik NS, Brüggenwirth HT et al. The role of DNA dependent protein kinase in synapsis of DNA ends. Nucleic Acids Res.31(24), 7238–7246 (2003).
  • Meek K, Douglas P, Cui X et al. Trans-autophosphorylation at DNA-dependent protein kinase’s two major autophosphorylation site clusters facilitates end processing but not end joining. Mol. Cell Biol.27(10), 3881–3890 (2007).
  • Mahajan KN, Gangi-Peterson L, Sorscher DH et al. Association of terminal deoxynucleotidyl transferase with Ku. Proc. Natl Acad. Sci. USA96(24), 13926–13931 (1999).
  • Mahajan KN, McElhinny SAN, Mitchell BS, Ramsden DA. Association of DNA polymerase µ (pol µ) with Ku and ligase IV: role for pol µ in end-joining double-strand break repair. Mol. Cell Biol.22(14), 5194–5202 (2002).
  • Ma Y, Pannicke U, Schwarz K, Lieber MR. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in non-homologous end joining and V(D)J recombination. Cell108(6), 781–794 (2002).
  • Gu J, Lu H, Tsai AG et al. Single-stranded DNA ligation and XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: influence of terminal DNA sequence. Nucleic Acids Res.35(17), 5755–5762 (2007).
  • Tsai CJ, Kim SA, Chu G. Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends. Proc. Natl Acad. Sci. USA104(19), 7851–7856 (2007).
  • Boboila C, Yan C, Wesemann DR et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J. Exp. Med.207(2), 417–427 (2010).
  • Boboila C, Jankovic M, Yan CT et al. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc. Natl Acad. Sci. USA107(7), 3034–3039 (2010).
  • Simsek D, Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat. Struct. Mol. Biol.17(4), 410–416 (2010).
  • Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell109(Suppl.), S45–S55 (2002).
  • Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu. Rev. Immunol.24, 541–570 (2006).
  • Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol.4, 541–552 (2004).
  • Franco S, Alt FW, Manis JP. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair (Amst).5(9–10), 1030–1041 (2006).
  • Muramatsu M, Kinoshita K, Fagarasan S et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell.102(5), 553–563 (2000).
  • Revy P, Muto T, Levy Y et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell102(5), 565–575 (2000).
  • Chaudhuri J, Tian M, Khuong C et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature422(6933), 726–730 (2003).
  • Sohail A, Klapacz J, Samaranayake M et al. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res.31(12), 2990–2994 (2003).
  • Daniel JA, Santos MA, Wang Z et al. PTIP promotes chromatin changes critical for immunoglobulin class switch recombination. Science329(5994), 914–915 (2010).
  • Chaudhuri J, Alt F. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol.4(7), 541–552 (2004).
  • Lumsden JM, McCarty T, Petiniot LK et al. Immunoglobulin class switch recombination is impaired in ATM-deficient mice. J. Exp. Med.200(9), 1111–1121 (2004).
  • Pan Q, Petit-Frére C, Lähdesmäki A et al. Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur. J. Immunol.32(5), 1300–1308 (2002).
  • Reina-San-Martin B, Chen HT, Nussenzweig A, Nussenzweig MC. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med.200(9), 1103–1110 (2004).
  • Lähdesmäki A, Taylor AM, Chrzanowska KH, Pan-Hammarström Q. Delineation of the role of the Mre11 complex in class switch recombination. J. Biol. Chem.279(16), 16479–16487 (2004).
  • Kracker S, Bergmann Y, Demuth I et al. Nibrin functions in Ig class-switch recombination. Proc. Natl Acad. Sci. USA102(5), 1584–1589 (2005).
  • Reina-San-Martin B, Nussenzweig MC, Nussenzweig A, Difilippantonio S. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking NBN. Proc. Natl Acad. Sci. USA102(5), 1590–1595 (2005).
  • Reina-San-Martin B, Difilippantonio S, Hanitsch L et al. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med.197, 1767–1778 (2003).
  • Lou Z, Minter-Dykhouse K, Franco S et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell21, 187–200 (2006).
  • Li L, Halaby MJ, Hakem A et al. RNF8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer. J. Exp. Med.207(5), 983–997 (2010).
  • Santos MA, Huen MS, Jankovic M et al. Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J. Exp. Med.207(5), 973–981 (2010).
  • Manis JP, Morales JC, Xia Z et al. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat. Immunol.5, 481–487 (2004).
  • Ward IM, Reina-San-Martin B, Olaru A et al. 53BP1 is required for class switch recombination. J. Cell Biol.165, 459–464 (2004).
  • Staples ER, McDermott EM, Reiman A et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin. Exp. Immunol.153(2), 214–220 (2008).
  • Khanna KK, Yan J, Watters D et al. Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells. J. Biol. Chem.272(14), 9489–9495 (1997).
  • Giovannetti A, Mazzetta F, Caprini E et al. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia. Blood100(12), 4082–4089 (2002).
  • Vacchio MS, Olaru A, Livak F, Hodes RJ. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor α locus coding end breaks. Proc. Natl Acad. Sci. USA104(15), 6323–6328 (2008).
  • Bredemeyer AL, Sharma GG, Huang CY et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature442, 466–470 (2006).
  • Aurias A, Dutrillaux B, Buriot D, Lejeune J. High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia. Mutat. Res.69(2), 369–374 (1980).
  • Mahowald GK, Baron JM, Mahowald MA et al. Aberrantly resolved RAG-mediated DNA breaks in ATM-deficient lymphocytes target chromosomal breakpoints in cis. Proc. Natl Acad. Sci. USA106(43), 18339–18344 (2009).
  • Carney JP, Maser RS, Olivares H et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell93(3), 477–486 (1998).
  • Varon R, Vissinga C, Platzer M et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell93(3), 467–476 (1998).
  • Weemaes CM, Smeets DF, van der Burgt CJ. Nijmegen Breakage syndrome: a progress report. Int. J. Radiat. Biol.66(Suppl. 6), S185–S188 (1994).
  • Chrzanowska KH, Kleijer WJ, Krajewska-Walasek M et al. Eleven Polish patients with microcephaly, immunodeficiency, and chromosomal instability: the Nijmegen breakage syndrome. Am. J. Med. Genet.57(3), 462–471 (1995).
  • Gregorek H, Chrzanowska KH, Michałkiewicz J et al. Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre. Clin. Exp. Immunol.130(2), 319–324 (2002).
  • Digweed M, Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst).3(8–9), 1207–1217 (2004).
  • Deriano L, Stracker TH, Baker A et al. Roles for NBN in alternative nonhomologous end-joining of V(D)J recombination intermediates. Mol. Cell34(1), 13–25 (2009).
  • Helmink BA, Bredemeyer AL, Lee BS et al. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J. Exp. Med.206(3), 669–679 (2009).
  • Stewart GS, Maser RS, Stankovic T et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell99(6), 577–587 (1999).
  • Delia D, Piane M, Buscemi G et al. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder. Hum. Mol. Genet.13(18), 2155–2163 (2004).
  • Fernet M, Gribaa M, Salih MA et al. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum. Mol. Genet.14(2), 307–318 (2005).
  • Waltes R, Kalb R, Gatei M et al. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am. J. Hum. Genet.84(5), 605–616 (2009).
  • Shull ER, Lee Y, Nakane H et al. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev.23(2), 171–180 (2009).
  • Warcoin M, Lespinasse J, Despouy G et al. Fertility defects revealing germline biallelic nonsense NBN mutations. Hum. Mutat.30(3), 424–430 (2009).
  • Riballo E, Critchlow SE, Teo SH et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol.9(13), 699–702 (1999).
  • O’Driscoll M, Cerosaletti KM, Girard PM et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell8(6), 1175–1185 (2001).
  • Ben-Omran TI, Cerosaletti K, Concannon P et al. A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome. Am. J. Med. Genet. A.137A(3), 283–287 (2005).
  • Buck D, Moshous D, de Chasseval R et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur. J. Immunol.36(1), 224–235 (2006).
  • Enders A, Fisch P, Schwarz K et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J. Immunol.176(8), 5060–5068 (2006).
  • van der Burg M, van Veelen LR, Verkaik NS et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J. Clin. Invest.116(1), 137–145 (2006).
  • Toita N, Hatano N, Ono S et al. Epstein-Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am. J. Med. Genet. A.143(7), 742–745 (2007).
  • Pan-Hammarström Q, Jones AM, Lähdesmäki A et al. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J. Exp. Med.201(2), 189–194 (2005).
  • Moshous D, Callebaut I, de Chasseval R et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell105(2), 177–186 (2001).
  • Li L, Moshous D, Zhou Y et al. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. J. Immunol.168(12), 6323–6329 (2002).
  • Kobayashi N, Agematsu K, Sugita K et al. Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families. Hum. Genet.112(4), 348–352 (2003).
  • Moshous D, Pannetier C, Chasseval Rd R et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J. Clin. Invest.111(3), 381–387 (2003).
  • Noordzij JG, Verkaik NS, van der Burg M et al. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. Blood101(4), 1446–1452 (2003).
  • Ege M, Ma Y, Manfras B et al. Omenn syndrome due to ARTEMIS mutations. Blood.105(11), 4179–4186 (2005).
  • Pannicke U, Hönig M, Schulze I, et al. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events. Hum. Mutat.31(2), 197–207 (2010).
  • Ahnesorg P, Smith P, Jackson SP. LF interacts with the XRCC4–DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell124(2), 301–313 (2006).
  • Buck D, Malivert L, de Chasseval R et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell124(2), 287–299 (2006).
  • Dutrannoy V, Demuth I, Baumann U et al. Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. Hum. Mutat.31(9), 1059–1068 (2010).
  • Rooney S, Sekiguchi J, Zhu C et al. Leaky SCID phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol. Cell10(6), 1379–1390 (2002).
  • Rooney S, Alt FW, Lombard D et al. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J. Exp. Med.197(5), 553–565 (2003).
  • Du L, van der Burg M, Popov SW et al. Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination. J. Exp. Med.205(13), 3031–3040 (2008).
  • Blunt T, Finnie NJ, Taccioli GE et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine SCID mutation. Cell80(5), 813–823 (1995).
  • Shin EK, Perryman LE, Meek K. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J. Immunol.158(8), 3565–3569 (1997).
  • van der Burg M, Ijspeert H, Verkaik NS et al. A DNA-PKCS mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J. Clin. Invest.119(1), 91–98 (2009).
  • Nussenzweig A, Chen C, da Costa Soares V et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature382(6591), 551–555 (1996).
  • Gu Y, Seidl KJ, Rathbun GA et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity7(5), 653–665 (1997).
  • Li G, Nelsen C, Hendrickson EA. Ku86 is essential in human somatic cells. Proc. Natl Acad. Sci. USA99(2), 832–837 (2002).
  • Stewart GS, Stankovic T, Byrd PJ et al. RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc. Natl Acad. Sci. USA104, 16910–16915 (2007).
  • Stewart GS, Panier S, Townsend K et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell136, 420–434 (2009).
  • Penengo L, Mapelli M, Murachelli AG et al. Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin. Cell124, 1183–1195 (2006).
  • Doil C, Mailand N, Bekker-Jensen S et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell136, 435–446 (2009).
  • Bekker-Jensen S, Rendtlew Danielsen J, Fugger K et al. HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat. Cell. Biol.12(1), 80–86 (2010).
  • Boulton SJ. DNA repair: Decision at the break point. Nature465(7296), 301–302 (2010).
  • Bothmer A, Robbiani DF, Feldhahn N et al. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J. Exp. Med.207(4), 855–865 (2010).
  • Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol.9(10), 759–769 (2008).
  • Laine A, Topisirovic I, Zhai D et al. Regulation of p53 localization and activity by Ubc13. Mol. Cell Biol.26(23), 8901–8913 (2006).
  • Topisirovic I, Gutierrez GJ, Chen M et al. Control of p53 multimerization by Ubc13 is JNK-regulated. Proc. Natl Acad. Sci. USA106(31), 12676–12681 (2009).
  • Laribee RN, Fuchs SM, Strahl BD. H2B ubiquitylation in transcriptional control: a FACT-finding mission. Genes Dev.21(7), 737–743 (2007).
  • Weake VM, Workman JL. Histone ubiquitination: triggering gene activity. Mol. Cell29(6), 653–663 (2008).
  • Wang H, Wang L, Erdjument-Bromage H et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature431(7010), 873–878 (2004).
  • Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell20(6), 845–854 (2005).
  • Zhou W, Zhu P, Wang J et al. Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol. Cell29(1), 69–80 (2008).
  • Wu J, Huen MS, Lu LY et al. Histone ubiquitination associates with BRCA1-dependent DNA damage response. Mol. Cell Biol.29(3), 849–860 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.